INZY - Inozyme Pharma  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INZY is currently covered by 5 analysts with an average price target of $17.24. This is a potential upside of $12.64 (274.78%) from yesterday's end of day stock price of $4.6.

Inozyme Pharma 's activity chart (see below) currently has 3 price targets and 18 ratings on display. The stock rating distribution of INZY is 71.43% BUY and 28.57% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20% with an average time for these price targets to be met of 5.4 days.

Highest price target for INZY is $23, Lowest price target is $15, average price target is $17.24.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 13-Mar-2024. First documented stock forecast 18-Aug-2020.

Best performing analysts who are covering INZY - Inozyme Pharma :

Suji Jeong David Nierengarten Christopher Raymond Edward White Joseph Stringer

Currently out of the existing stock ratings of INZY, 10 are a BUY (71.43%), 4 are a HOLD (28.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

16

$11.4 (247.83%)

16

1 months 25 days ago

0/4 (0%)

$10.23 (177.30%)

Buy

15

$10.4 (226.09%)

15

3 months 8 days ago

0/3 (0%)

$9.46 (170.76%)

Buy

23

$18.4 (400.00%)

23

8 months 29 days ago

0/5 (0%)

$18.1 (369.39%)

Hold

6

$1.4 (30.43%)

5

1 years 1 months 15 days ago

2/2 (100%)

$2.7 (81.82%)

27

Buy

40

$35.8 (852.38%)

3 years 4 days ago

0/1 (0%)

$22.69 (131.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INZY (Inozyme Pharma ) average time for price targets to be met?

On average it took 5.4 days on average for the stock forecasts to be realized with a an average price target met ratio 20

Which analyst has the current highest performing score on INZY (Inozyme Pharma ) with a proven track record?

SUJI JEONG

Which analyst has the current lower performing score on INZY (Inozyme Pharma ) with a proven track record?

JOSEPH STRINGER

Which analyst has the most public recommendations on INZY (Inozyme Pharma )?

Suji Jeong has 3 price targets and 2 ratings on INZY

Which analyst is the currently most bullish on INZY (Inozyme Pharma )?

Christopher Raymond with highest potential upside - $35.8

Which analyst is the currently most reserved on INZY (Inozyme Pharma )?

Suji Jeong with lowest potential downside - $1.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?